271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

18 trials found

diseases per page:

Showing 1 to 10 of 18 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05164198 (ClinicalTrials.gov)	January 15, 2022	8/11/2021	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Ankylosing Spondylitis;Axial Spondyloarthritis	Biological: Adalimumab and its biosimilars;Biological: Biological: Etanercept and its biosimilars;Biol ...	Hanyang University Seoul Hospital	Linical Korea	Not yet recruiting	18 Years	65 Years	All	448	Phase 4	NULL
2	NCT03733925 (ClinicalTrials.gov)	January 7, 2019	5/11/2018	A Study of Golimumabin the Treatment of Indian Participants With Active Spondyloarthropathy of Ankyl ...	A Phase-IV, Multicenter, Noncomparative, Open-Label Study Evaluating the Safety and Efficacy of Goli ...	Spondylitis, Ankylosing;Arthritis, Psoriatic	Drug: Golimumab	Johnson & Johnson Private Limited	NULL	Completed	18 Years	N/A	All	100	Phase 4	India
3	NCT02758782 (ClinicalTrials.gov)	September 2016	20/4/2016	NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage i ...	COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy ...	Ankylosing Spondylitis	Biological: Golimumab;Drug: Celecoxib	Charite University, Berlin, Germany	NULL	Completed	18 Years	N/A	All	156	Phase 4	Germany
4	NCT03557853 (ClinicalTrials.gov)	June 2016	5/6/2018	Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated ...	A Prospective Observational Study to Evaluate Clinical and Radiological Manifestations of Coxitis in ...	Ankylosing Spondylitis;Coxitis	Drug: Golimumab Injection	MSD Pharmaceuticals LLC	NULL	Unknown status	18 Years	N/A	All	39		Russian Federation
5	EUCTR2015-002284-42-FI (EUCTR)	18/09/2015	28/08/2015	The rationale for this study is to gain insight in the extent and impact of immunogenicityof TNF inh ...	INTENT: immunogenicity in patients failing response on anti-TNF-Immunogenicity and pharmacokinetics ...	rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis.;Therapeutic area: N ...	Trade Name: Enbrel Product Name: etanercept Trade Name: Humira Product Name: adalimumab Trade Name: Cimz ...	READE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1650	Phase 1	Finland
6	EUCTR2014-000241-74-DE (EUCTR)	30/12/2014	01/10/2014	A Study of Golimumab in Participants with Active Ankylosing Spondylitis	A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFa Monoclo ...	Ankylosing spondylitis (AS) MedDRA version: 19.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: golimumab INN or Proposed INN: GOLIMUMAB Other descriptive name: Human anti-TNFa monoclo ...	Janssen Biologics, BV	NULL	Not Recruiting			Female: yes Male: yes	200	Phase 3	United States;Mexico;Canada;Poland;Brazil;Ukraine;Romania;Australia;Russian Federation;Germany;Korea ...
7	NCT02186873 (ClinicalTrials.gov)	September 3, 2014	8/7/2014	A Study of Golimumab in Participants With Active Ankylosing Spondylitis	A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFa Monoclo ...	Ankylosing Spondylitis	Drug: Placebo;Drug: Golimumab	Janssen Research & Development, LLC	NULL	Completed	18 Years	N/A	All	208	Phase 3	United States;Australia;Canada;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Ukraine;B ...
8	NCT01668004 (ClinicalTrials.gov)	September 3, 2012	1/8/2012	The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated ...	Open-Label, Phase 4 Study, Investigating the Incidence of Extra-Articular Manifestations in Subjects ...	Ankylosing Spondylitis	Biological: Golimumab	Merck Sharp & Dohme Corp.	NULL	Completed	18 Years	N/A	All	101	Phase 4	Netherlands
9	EUCTR2012-002458-21-NL (EUCTR)	23/07/2012	03/07/2012	Open-label, Phase 4 Study, investigation of the frequency of Extra-Articular exposure in patients wi ...	Open-label, Phase 4 Study, investigating the Incidence of Extra-Articular Manifestations in Subjects ...	Ankylosing Spondylitis(Bechterew disease) MedDRA version: 14.1;Level: LLT;Classification code 100025 ...	Trade Name: Simponi INN or Proposed INN: GOLIMUMAB	MERCK SHARP & DOHME B.V.	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 4	Netherlands
10	NCT01610947 (ClinicalTrials.gov)	May 14, 2012	24/5/2012	Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity	Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity: a Randomize ...	Spondyloarthritis	Drug: Adalimumab , Etanercept, Golimumab or infliximab	University Hospital, Montpellier	NULL	Completed	18 Years	N/A	All	398	N/A	France

First Previous1 2Next Last